Brief: Neubase Therapeutics Reports Business Update And Financial Results For Fiscal Year 2022
21/12/2022 13:07
NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS BUSINESS UPDATE AND FINANCIAL
RESULTS FOR FISCAL YEAR 2022
* NEUBASE THERAPEUTICS INC FY LOSS PER SHARE $1.04
Source text for Eikon: ID:nGNX4lP4LJ
Further company coverage: NBSE.O
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet